Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).
Slomovitz BM, Weroha SJ, Deng W, Chon HS, Podder V, Jenkins Vogel MT, Backes F, Thomas ED, Chen LM, Tenney ME, Westin SN, Markham MJ, Miller DS, Edelson MI, Muller CY, Callahan MJ, Holman LL, Liu JR, Teplinsky E, Kamat A, Guy M, Chern JY, Lea J, Murphy M, Choong GM, Moore ED, Alvarez EA, Rodgers WH, O'Malley DM, Copeland LJ, Herzog TJ, Coleman RL, Gershenson DM.
Slomovitz BM, et al. Among authors: thomas ed.
J Clin Oncol. 2026 Jan 20;44(3):153-163. doi: 10.1200/JCO-25-01348. Epub 2025 Dec 12.
J Clin Oncol. 2026.
PMID: 41385758
Clinical Trial.